GESTIÓN EN SALUD PÚBLICA: Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine | National Institutes of Health (NIH)

martes, 29 de junio de 2021

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine | National Institutes of Health (NIH)

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine | National Institutes of Health (NIH)

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)